110 related articles for article (PubMed ID: 10995763)
1. Tyrosine phosphorylation of the kappa -opioid receptor regulates agonist efficacy.
Appleyard SM; McLaughlin JP; Chavkin C
J Biol Chem; 2000 Dec; 275(49):38281-5. PubMed ID: 10995763
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation of the mu-opioid receptor regulates agonist intrinsic efficacy.
McLaughlin JP; Chavkin C
Mol Pharmacol; 2001 Jun; 59(6):1360-8. PubMed ID: 11353794
[TBL] [Abstract][Full Text] [Related]
3. Agonist-dependent desensitization of the kappa opioid receptor by G protein receptor kinase and beta-arrestin.
Appleyard SM; Celver J; Pineda V; Kovoor A; Wayman GA; Chavkin C
J Biol Chem; 1999 Aug; 274(34):23802-7. PubMed ID: 10446141
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphorylation of Kir3 following kappa-opioid receptor activation of p38 MAPK causes heterologous desensitization.
Clayton CC; Xu M; Chavkin C
J Biol Chem; 2009 Nov; 284(46):31872-81. PubMed ID: 19773548
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization.
McLaughlin JP; Xu M; Mackie K; Chavkin C
J Biol Chem; 2003 Sep; 278(36):34631-40. PubMed ID: 12815037
[TBL] [Abstract][Full Text] [Related]
6. Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes.
Henry DJ; Grandy DK; Lester HA; Davidson N; Chavkin C
Mol Pharmacol; 1995 Mar; 47(3):551-7. PubMed ID: 7700253
[TBL] [Abstract][Full Text] [Related]
7. Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.
Margolis EB; Hjelmstad GO; Bonci A; Fields HL
J Neurosci; 2003 Nov; 23(31):9981-6. PubMed ID: 14602811
[TBL] [Abstract][Full Text] [Related]
8. Selective interference of beta-arrestin 1 with kappa and delta but not mu opioid receptor/G protein coupling.
Cheng ZJ; Yu QM; Wu YL; Ma L; Pei G
J Biol Chem; 1998 Sep; 273(38):24328-33. PubMed ID: 9733719
[TBL] [Abstract][Full Text] [Related]
9. kappa-Opioid receptor activates an inwardly rectifying K+ channel by a G protein-linked mechanism: coexpression in Xenopus oocytes.
Ma GH; Miller RJ; Kuznetsov A; Philipson LH
Mol Pharmacol; 1995 May; 47(5):1035-40. PubMed ID: 7746270
[TBL] [Abstract][Full Text] [Related]
10. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
[TBL] [Abstract][Full Text] [Related]
11. Repeated stress dysregulates κ-opioid receptor signaling in the dorsal raphe through a p38α MAPK-dependent mechanism.
Lemos JC; Roth CA; Messinger DI; Gill HK; Phillips PE; Chavkin C
J Neurosci; 2012 Sep; 32(36):12325-36. PubMed ID: 22956823
[TBL] [Abstract][Full Text] [Related]
12. Acute suppression of inwardly rectifying Kir2.1 channels by direct tyrosine kinase phosphorylation.
Wischmeyer E; Döring F; Karschin A
J Biol Chem; 1998 Dec; 273(51):34063-8. PubMed ID: 9852063
[TBL] [Abstract][Full Text] [Related]
13. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship studies of functionally selective kappa opioid receptor agonists that modulate ERK 1/2 phosphorylation while preserving G protein over βarrestin2 signaling bias.
Lovell KM; Frankowski KJ; Stahl EL; Slauson SR; Yoo E; Prisinzano TE; Aubé J; Bohn LM
ACS Chem Neurosci; 2015 Aug; 6(8):1411-9. PubMed ID: 25891774
[TBL] [Abstract][Full Text] [Related]
15. Allosterism within
Jacobs BA; Pando MM; Jennings E; Chavera TA; Clarke WP; Berg KA
Mol Pharmacol; 2018 Apr; 93(4):376-386. PubMed ID: 29436492
[TBL] [Abstract][Full Text] [Related]
16. Functional couplings of the delta- and the kappa-opioid receptors with the G-protein-activated K+ channel.
Ikeda K; Kobayashi T; Ichikawa T; Usui H; Kumanishi T
Biochem Biophys Res Commun; 1995 Mar; 208(1):302-8. PubMed ID: 7887943
[TBL] [Abstract][Full Text] [Related]
17. TrkB activation by brain-derived neurotrophic factor inhibits the G protein-gated inward rectifier Kir3 by tyrosine phosphorylation of the channel.
Rogalski SL; Appleyard SM; Pattillo A; Terman GW; Chavkin C
J Biol Chem; 2000 Aug; 275(33):25082-8. PubMed ID: 10833508
[TBL] [Abstract][Full Text] [Related]
18. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor.
Kong H; Raynor K; Yano H; Takeda J; Bell GI; Reisine T
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8042-6. PubMed ID: 8058754
[TBL] [Abstract][Full Text] [Related]
19. Repeated administration of the selective kappa-opioid receptor agonist U-69593 increases stimulated dopamine extracellular levels in the rat nucleus accumbens.
Fuentealba JA; Gysling K; Magendzo K; Andrés ME
J Neurosci Res; 2006 Aug; 84(2):450-9. PubMed ID: 16676328
[TBL] [Abstract][Full Text] [Related]
20. Repeated treatment with the κ-opioid agonist U-69593 increases K+-stimulated dopamine release in the rat medial prefrontal cortex.
Fuentealba JA; Gysling K; Andrés ME
Synapse; 2010 Dec; 64(12):898-904. PubMed ID: 20939060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
